Skip to Content

SEC Filings

Filing date	Form	Description	View
Feb 12, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001258897-20-001153.pdf 0001258897-20-001153.rtf 0001258897-20-001153.xls View HTML
Dec 03, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-304912.pdf 0001193125-19-304912.rtf 0001193125-19-304912.xls View HTML
Dec 03, 2019	8-A12G	Registration of certain classes of securities 12(g) of the Securities Exchange Act	0001193125-19-304913.pdf 0001193125-19-304913.rtf 0001193125-19-304913.xls View HTML
Nov 19, 2019	SC 13D/A	An amendment to a SC 13D filing	0000921895-19-002823.pdf 0000921895-19-002823.rtf 0000921895-19-002823.xls View HTML
Nov 12, 2019	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-19-042925.pdf 0001564590-19-042925.rtf 0001564590-19-042925.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Oct 21, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-270407.pdf 0001193125-19-270407.rtf 0001193125-19-270407.xls View HTML
Oct 21, 2019	4	Statement of changes in beneficial ownership of securities	0000899243-19-025789.pdf 0000899243-19-025789.rtf View HTML
Oct 21, 2019	4	Statement of changes in beneficial ownership of securities	0000899243-19-025791.pdf 0000899243-19-025791.rtf View HTML
Oct 21, 2019	4	Statement of changes in beneficial ownership of securities	0000899243-19-025794.pdf 0000899243-19-025794.rtf View HTML
Sep 30, 2019	SC 13D/A	An amendment to a SC 13D filing	0001193125-19-257723.pdf 0001193125-19-257723.rtf 0001193125-19-257723.xls View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-441-1000
info@merrimack.com

© 2020 Merrimack Pharmaceuticals.